Jack Hirsh
Jack Hirsh publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Antiplatelet Therapy and Cardiovascular Diseases.
- World rank
- #27,218 of 7,710,434 ranked researchers
- Rank in Canada
- #654 of 183,316
- Works
- 420
- Citations
- 55k
- Citations per work
- 131.9
What does Jack Hirsh research?
Jack Hirsh's work is mostly in Medicine (81%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences33980.7%
- Medicine33980.7%
- Everything else8119.3%
- 1Cardiology and Cardiovascular Medicine31% of their works
- 2Internal Medicine22% of their works
- 3Surgery12% of their works
- 4Hematology10% of their works
- 5Epidemiology3% of their works
- 6Pulmonary and Respiratory Medicine2% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood Coagulation and Thrombosis Mechanisms
- Heparin-Induced Thrombocytopenia and Thrombosis
- Acute Myocardial Infarction Research
- Platelet Disorders and Treatments
- Acute Ischemic Stroke Management
Which keywords describe Jack Hirsh's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Risk Factors, Pulmonary Embolism, Venous Thromboembolism, Guidelines, Anticoagulant Therapy and Atrial Fibrillation.
- Ischemic Stroke
- Immune Thrombocytopenic Purpura
- Acute Coronary Syndromes
- Heparin-Induced Thrombocytopenia
- Protease-Activated Receptors
- Aspirin
- Inflammation
- Atrial Fibrillation
- Guidelines
- Pulmonary Embolism
- Diagnosis
- Antithrombotic Therapy
- Risk Factors
- Venous Thromboembolism
- Anticoagulant Therapy
- Hemostasis
- Thrombosis
- Clopidogrel
- Thrombin
- Vaccination
- Myocardial Infarction
- Platelets
- Thrombolysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Antithrombotic Therapy3402 topics
- Diagnosis3262 topics
- Risk Factors2802 topics
- Pulmonary Embolism2581 topic
- Venous Thromboembolism2581 topic
- Guidelines2142 topics
- Anticoagulant Therapy1591 topic
- Atrial Fibrillation1591 topic
- Hemostasis1062 topics
- Inflammation1062 topics
- Thrombosis922 topics
- Aspirin851 topic
- Clopidogrel851 topic
- Protease-Activated Receptors821 topic
- Thrombin821 topic
- Heparin-Induced Thrombocytopenia681 topic
- Vaccination681 topic
- Acute Coronary Syndromes551 topic
- Myocardial Infarction551 topic
- Immune Thrombocytopenic Purpura241 topic
- Platelets241 topic
- Ischemic Stroke221 topic
- Thrombolysis221 topic
Where does Jack Hirsh work?
Jack Hirsh's main affiliation in the publication record is McMaster University, Canada.
How many publications and citations does Jack Hirsh have?
OpenAlex counts 420 works and 55,416 citations for Jack Hirsh, an h-index of 112, ranking #27,218 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jack Hirsh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.